US Stock MarketDetailed Quotes

ZVRA Zevra Therapeutics

Watchlist

9.585
+0.455+4.98%

Close Nov 22 16:00 ET

9.640
+0.055+0.57%

Post 20:01 ET

511.61MMarket Cap-4500P/E (TTM)

Zevra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-291.98%-18.14M

-119.54%-19.11M

-299.63%-16.17M

-79.17%-33.54M

-262.12%-16.16M

29.86%-4.63M

-112.09%-8.7M

-13.85%-4.05M

-279.30%-18.72M

-426.18%-4.46M

Net income from continuing operations

-220.49%-33.23M

-674.39%-19.93M

-25.76%-16.62M

-72.00%-46.05M

-445.95%-19.89M

-56.70%-10.37M

89.30%-2.57M

-609.07%-13.22M

-212.94%-26.77M

312.73%5.75M

Operating gains losses

237.86%4.71M

-202.49%-5.82M

-360.38%-3.4M

100.37%57K

127.34%4.09M

-15,413.64%-3.41M

-8,265.22%-1.92M

641.49%1.31M

-194.09%-15.24M

-22,559.09%-14.96M

Depreciation and amortization

2,508.06%1.62M

1,902.56%1.56M

1,877.22%1.56M

6.57%1.01M

162.33%787K

-84.42%62K

-56.91%78K

21.54%79K

267.32%944K

368.75%300K

Other non cash items

1,208.45%929K

2,556.00%664K

602.38%295K

-98.73%227K

50.85%89K

9.23%71K

-99.86%25K

-16.00%42K

3,788.48%17.89M

-21.33%59K

Change In working capital

-103.08%-239K

77.25%-1.44M

-102.12%-148K

1,549.01%5.88M

-172.89%-2.54M

626.61%7.76M

-1,628.99%-6.33M

346.98%7M

-13.73%-406K

263.50%3.49M

-Change in receivables

-71.82%1.16M

89.66%-642K

1,801.89%9.07M

-34.05%-9.08M

-250.42%-7.45M

222.42%4.11M

-1,342.20%-6.21M

126.62%477K

-744.34%-6.77M

-2,436.26%-2.13M

-Change in inventory

-996.92%-583K

-1,439.19%-991K

-5,168.63%-2.59M

40.14%206K

112.03%16K

-73.03%65K

89.74%74K

--51K

--147K

---133K

-Change in prepaid assets

13.26%410K

21.19%-818K

-106.26%-44K

117.00%152K

-58.61%125K

-47.99%362K

52.71%-1.04M

132.01%703K

-8.36%-894K

-44.18%302K

-Change in payables and accrued expense

-181.04%-1.99M

-45.78%-1.3M

-290.46%-7.31M

255.48%11.13M

206.58%5.73M

288.13%2.45M

-179.66%-889K

889.30%3.84M

381.31%3.13M

140.23%1.87M

-Change in other current assets

927.27%91K

116.05%175K

53.75%123K

-51.58%321K

-70.57%171K

-110.38%-11K

208.00%81K

56.86%80K

398.50%663K

1,191.11%581K

-Change in other current liabilities

-9,150.00%-1.48M

473.81%482K

-232.92%-428K

82.94%-79K

-779.71%-469K

89.74%-16K

-84.24%84K

135.42%322K

-216.62%-463K

113.91%69K

-Change in other working capital

169.92%2.15M

5.16%1.65M

-33.25%1.02M

-14.57%3.23M

-122.71%-664K

120.44%798K

--1.57M

--1.53M

--3.78M

--2.92M

Cash from discontinued investing activities

Operating cash flow

-291.98%-18.14M

-119.54%-19.11M

-299.63%-16.17M

-79.17%-33.54M

-262.12%-16.16M

29.86%-4.63M

-112.09%-8.7M

-13.85%-4.05M

-279.30%-18.72M

-426.18%-4.46M

Investing cash flow

Cash flow from continuing investing activities

29.47%-31.35M

-100.38%-129K

184.27%14.79M

52.64%-17.39M

16,901.59%10.59M

-16,444.12%-44.46M

202.89%34.04M

-356.21%-17.56M

-136.53%-36.72M

99.59%-63K

Net PPE purchase and sale

--0

-218.28%-296K

-111.76%-72K

-514.29%-172K

-53.33%-23K

-81.25%-29K

8.82%-93K

-100.00%-34K

Net business purchase and sale

----

-115.76%-30.4M

----

---14.09M

--0

Net investment purchase and sale

29.20%-31.35M

-100.38%-129K

184.41%14.79M

159.05%13.31M

141,679.31%41.06M

-14,861.33%-44.28M

279.49%34.06M

-357.36%-17.53M

-46.13%-22.54M

99.81%-29K

Cash from discontinued investing activities

Investing cash flow

29.47%-31.35M

-100.38%-129K

184.27%14.79M

52.64%-17.39M

16,901.59%10.59M

-16,444.12%-44.46M

202.89%34.04M

-356.21%-17.56M

-136.53%-36.72M

99.59%-63K

Financing cash flow

Cash flow from continuing financing activities

146.64%64.77M

1,511.99%15.33M

132.45%1.22M

240.80%28.46M

2,047.08%5M

6,520.29%26.26M

-93.08%951K

20.77%-3.75M

-92.62%8.35M

91.05%-257K

Net issuance payments of debt

--0

5,159.01%16.29M

--0

94.74%24.9M

-36,600.00%-1.1M

1,310,400.00%26.21M

-102.52%-322K

1,220.00%112K

133.56%12.78M

82.35%-3K

Net common stock issuance

--64.67M

---71K

135.31%1.22M

156.30%2.66M

--6.11M

--0

27.02%-3.45M

-110.16%-4.72M

--0

Proceeds from stock option exercised by employees

73.58%92K

----

-32.72%218K

-100.93%-1K

--53K

----

-98.95%324K

--108K

Net other financing activities

--0

----

2,196.97%692K

--0

--1.11M

---415K

-100.04%-33K

-828.21%-362K

Cash from discontinued financing activities

Financing cash flow

146.64%64.77M

1,511.99%15.33M

132.45%1.22M

240.80%28.46M

2,047.08%5M

6,520.29%26.26M

-93.08%951K

20.77%-3.75M

-92.62%8.35M

91.05%-257K

Net cash flow

Beginning cash position

-40.69%39.26M

6.64%42.85M

-34.24%43.05M

-41.73%65.47M

-38.24%43.27M

-13.78%66.2M

-59.90%40.18M

-41.73%65.47M

2,499.40%112.35M

-46.72%70.06M

Current changes in cash

166.90%15.27M

-114.87%-3.91M

99.39%-155K

52.30%-22.46M

88.10%-569K

-238.90%-22.83M

212.16%26.28M

-108.92%-25.35M

-143.59%-47.08M

75.04%-4.78M

Effect of exchange rate changes

-381.37%-491K

219.03%319K

-169.23%-45K

-78.43%44K

84.66%349K

-780.00%-102K

---268K

--65K

--204K

--189K

End cash Position

24.89%54.04M

-40.69%39.26M

6.64%42.85M

-34.24%43.05M

-38.24%43.27M

-13.78%66.2M

-59.90%40.18M

-41.73%65.47M

Free cash flow

-277.94%-18.14M

-118.96%-19.11M

-296.78%-16.17M

-79.86%-33.83M

-260.99%-16.23M

27.56%-4.8M

-111.87%-8.73M

-14.15%-4.07M

-281.97%-18.81M

-419.77%-4.5M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-291.98%-18.14M	-119.54%-19.11M	-299.63%-16.17M	-79.17%-33.54M	-262.12%-16.16M	29.86%-4.63M	-112.09%-8.7M	-13.85%-4.05M	-279.30%-18.72M	-426.18%-4.46M
Net income from continuing operations	-220.49%-33.23M	-674.39%-19.93M	-25.76%-16.62M	-72.00%-46.05M	-445.95%-19.89M	-56.70%-10.37M	89.30%-2.57M	-609.07%-13.22M	-212.94%-26.77M	312.73%5.75M
Operating gains losses	237.86%4.71M	-202.49%-5.82M	-360.38%-3.4M	100.37%57K	127.34%4.09M	-15,413.64%-3.41M	-8,265.22%-1.92M	641.49%1.31M	-194.09%-15.24M	-22,559.09%-14.96M
Depreciation and amortization	2,508.06%1.62M	1,902.56%1.56M	1,877.22%1.56M	6.57%1.01M	162.33%787K	-84.42%62K	-56.91%78K	21.54%79K	267.32%944K	368.75%300K
Other non cash items	1,208.45%929K	2,556.00%664K	602.38%295K	-98.73%227K	50.85%89K	9.23%71K	-99.86%25K	-16.00%42K	3,788.48%17.89M	-21.33%59K
Change In working capital	-103.08%-239K	77.25%-1.44M	-102.12%-148K	1,549.01%5.88M	-172.89%-2.54M	626.61%7.76M	-1,628.99%-6.33M	346.98%7M	-13.73%-406K	263.50%3.49M
-Change in receivables	-71.82%1.16M	89.66%-642K	1,801.89%9.07M	-34.05%-9.08M	-250.42%-7.45M	222.42%4.11M	-1,342.20%-6.21M	126.62%477K	-744.34%-6.77M	-2,436.26%-2.13M
-Change in inventory	-996.92%-583K	-1,439.19%-991K	-5,168.63%-2.59M	40.14%206K	112.03%16K	-73.03%65K	89.74%74K	--51K	--147K	---133K
-Change in prepaid assets	13.26%410K	21.19%-818K	-106.26%-44K	117.00%152K	-58.61%125K	-47.99%362K	52.71%-1.04M	132.01%703K	-8.36%-894K	-44.18%302K
-Change in payables and accrued expense	-181.04%-1.99M	-45.78%-1.3M	-290.46%-7.31M	255.48%11.13M	206.58%5.73M	288.13%2.45M	-179.66%-889K	889.30%3.84M	381.31%3.13M	140.23%1.87M
-Change in other current assets	927.27%91K	116.05%175K	53.75%123K	-51.58%321K	-70.57%171K	-110.38%-11K	208.00%81K	56.86%80K	398.50%663K	1,191.11%581K
-Change in other current liabilities	-9,150.00%-1.48M	473.81%482K	-232.92%-428K	82.94%-79K	-779.71%-469K	89.74%-16K	-84.24%84K	135.42%322K	-216.62%-463K	113.91%69K
-Change in other working capital	169.92%2.15M	5.16%1.65M	-33.25%1.02M	-14.57%3.23M	-122.71%-664K	120.44%798K	--1.57M	--1.53M	--3.78M	--2.92M
Cash from discontinued investing activities
Operating cash flow	-291.98%-18.14M	-119.54%-19.11M	-299.63%-16.17M	-79.17%-33.54M	-262.12%-16.16M	29.86%-4.63M	-112.09%-8.7M	-13.85%-4.05M	-279.30%-18.72M	-426.18%-4.46M
Investing cash flow
Cash flow from continuing investing activities	29.47%-31.35M	-100.38%-129K	184.27%14.79M	52.64%-17.39M	16,901.59%10.59M	-16,444.12%-44.46M	202.89%34.04M	-356.21%-17.56M	-136.53%-36.72M	99.59%-63K
Net PPE purchase and sale	--0	--0	--0	-218.28%-296K	-111.76%-72K	-514.29%-172K	-53.33%-23K	-81.25%-29K	8.82%-93K	-100.00%-34K
Net business purchase and sale	----	----	----	-115.76%-30.4M	----	----	----	----	---14.09M	--0
Net investment purchase and sale	29.20%-31.35M	-100.38%-129K	184.41%14.79M	159.05%13.31M	141,679.31%41.06M	-14,861.33%-44.28M	279.49%34.06M	-357.36%-17.53M	-46.13%-22.54M	99.81%-29K
Cash from discontinued investing activities
Investing cash flow	29.47%-31.35M	-100.38%-129K	184.27%14.79M	52.64%-17.39M	16,901.59%10.59M	-16,444.12%-44.46M	202.89%34.04M	-356.21%-17.56M	-136.53%-36.72M	99.59%-63K
Financing cash flow
Cash flow from continuing financing activities	146.64%64.77M	1,511.99%15.33M	132.45%1.22M	240.80%28.46M	2,047.08%5M	6,520.29%26.26M	-93.08%951K	20.77%-3.75M	-92.62%8.35M	91.05%-257K
Net issuance payments of debt	--0	5,159.01%16.29M	--0	94.74%24.9M	-36,600.00%-1.1M	1,310,400.00%26.21M	-102.52%-322K	1,220.00%112K	133.56%12.78M	82.35%-3K
Net common stock issuance	--64.67M	---71K	135.31%1.22M	156.30%2.66M	--6.11M	--0	--0	27.02%-3.45M	-110.16%-4.72M	--0
Proceeds from stock option exercised by employees	73.58%92K	----	----	-32.72%218K	-100.93%-1K	--53K	----	----	-98.95%324K	--108K
Net other financing activities	--0	----	----	2,196.97%692K	--0	--0	--1.11M	---415K	-100.04%-33K	-828.21%-362K
Cash from discontinued financing activities
Financing cash flow	146.64%64.77M	1,511.99%15.33M	132.45%1.22M	240.80%28.46M	2,047.08%5M	6,520.29%26.26M	-93.08%951K	20.77%-3.75M	-92.62%8.35M	91.05%-257K
Net cash flow
Beginning cash position	-40.69%39.26M	6.64%42.85M	-34.24%43.05M	-41.73%65.47M	-38.24%43.27M	-13.78%66.2M	-59.90%40.18M	-41.73%65.47M	2,499.40%112.35M	-46.72%70.06M
Current changes in cash	166.90%15.27M	-114.87%-3.91M	99.39%-155K	52.30%-22.46M	88.10%-569K	-238.90%-22.83M	212.16%26.28M	-108.92%-25.35M	-143.59%-47.08M	75.04%-4.78M
Effect of exchange rate changes	-381.37%-491K	219.03%319K	-169.23%-45K	-78.43%44K	84.66%349K	-780.00%-102K	---268K	--65K	--204K	--189K
End cash Position	24.89%54.04M	-40.69%39.26M	6.64%42.85M	-34.24%43.05M	-34.24%43.05M	-38.24%43.27M	-13.78%66.2M	-59.90%40.18M	-41.73%65.47M	-41.73%65.47M
Free cash flow	-277.94%-18.14M	-118.96%-19.11M	-296.78%-16.17M	-79.86%-33.83M	-260.99%-16.23M	27.56%-4.8M	-111.87%-8.73M	-14.15%-4.07M	-281.97%-18.81M	-419.77%-4.5M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data